Journal of Clinical Medicine Research · 2018 · 21 citations · 13 references
MedicineNephrologyPharmacologyClinical PharmacologyRenal PathophysiologyRenal PharmacotherapyAcute Kidney InjuryAnticoagulant TherapyInterstitial NephritisRenal DiseaseRenal PharmacologyTubulointerstitial DiseasesDrug-induced Acute Kidney InjuryMedication-associated Acute Kidney InjuryMedication-related NephrotoxicityNonsteroidal Anti-inflammatory Drug - Induced Interstitial NephritisProton Pump Inhibitor - Induced Interstitial NephritisRenal Biopsy FindingsTubulointerstitial Nephritis SyndromeUrinary Urea Nitrogen
Acute kidney injury (AKI) due to an acute interstitial nephritis (AIN) is common and can lead to increased morbidity and mortality. Medications such as antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPI) and rifampin are common offending agents. Anticoagulant-associated AIN is more frequently reported with the use of warfarin; however, only few case reports have reported an association with the use of novel oral anticoagulants (NOACs). Herein, we report the case of a 59-year-old male who developed AKI after initiating dabigatran for the treatment of atrial fibrillation. Laboratory data demonstrated elevated blood urea nitrogen (BUN) of 115 mg/dL (baseline = 35 mg/dL) and serum creatinine (Cr) of 5.06 mg/dL (baseline = 1.3 mg/dL). Urinalysis revealed eosinophiluria. Renal biopsy disclosed diffuse tubulointerstitial nephritis and eosinophils and confirmed the diagnosis of AIN. At 1 week, renal function improved (BUN/Cr = 53/2.73 mg/dL) with steroid therapy and discontinuation of dabigatran. With an increasing use of NOACs, it is important to monitor renal function to diagnose AIN in a timely fashion. Early diagnosis and prompt treatment can mitigate serious renal damage induced by dabigatran.
13
Diagnosis and management of acute interstitial nephritis.
Charles Kodner, Archana Kudrimoti · PubMed · 2003 · 179 citations